Comparison of 2SC, AKR1B10, and FH Antibodies as Potential Biomarkers for FH-deficient Uterine Leiomyomas

Ahvenainen, T; Kaukomaa, J; Kampjarvi, K; Uimari, O; Ahtikoski, A; Makinen, N; Heikinheimo, O; Aaltonen, LA; Karhu, A; Butzow, R; Vahteristo, P

Vahteristo, P (通讯作者),Univ Helsinki, Appl Tumor Genom Res Program, Biomed Helsinki, POB 63 Haartmaninkatu 8, FIN-00014 Helsinki, Finland.;Vahteristo, P (通讯作者),Univ Helsinki, Dept Med & Clin Genet, Biomed Helsinki, POB 63 Haartmaninkatu 8, FIN-00014 Helsinki, Finland.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2022; 46 (4): 537

Abstract

Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a tumor predisposition syndrome caused by germline fumarate hydratase (FH) mutations and ch......

Full Text Link